Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve

Thrombocytopenia in patients with chronic hepatitis C negatively impacts interferon (IFN)-based treatment. The aim of this study was to evaluate the efficacy and safety of telaprevir (TVR)-based triple therapy including IFN for patients who have undergone partial splenic arterial embolization (PSE)....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Exp Ther Med
Glavni autori: ISHIKAWA, TORU, ABE, SATOSHI, KOJIMA, YUICHI, HORIGOME, RYOKO, SANO, TOMOE, IWANAGA, AKITO, SEKI, KEIICHI, HONMA, TERASU, YOSHIDA, TOSHIAKI
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2015
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577936/
https://ncbi.nlm.nih.gov/pubmed/26622488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2674
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items